Relabující autoimunitní pankreatitida 1. typu: kazuistika

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Relapsing autoimmune pancreatitis type 1: Case report
Authors

ONDREJKOVÁ Alena KIANIČKA Bohuslav NECHUTOVÁ Hana HRUŠKA Lukáš NOVOTNÝ Ivo SOUČEK Miroslav

Year of publication 2017
Type Article in Periodical
Magazine / Source Vnitřní lékařství
MU Faculty or unit

Faculty of Medicine

Citation
Field Other medical specializations
Keywords Autoimmune pancreatitis type 1; Long-term follow-up; Relapse; Therapy
Description Autoimmune pancreatitis (AIP) is a rare form of chronic pancreatitis, classifed into 2 subtypes-AIP type 1 and AIP type 2. We present a case of a 31-years-old female admitted to our institution with upper abdominal pain and obstructive jaundice. Endoscopic retrograde cholangiopancreatoscopy (ERCP) revealed stenosis of intrapancreatic distal bile duct. Difuse parenchymal enlargement and typical features of AIP were shown by computed tomography (CT) and endoscopic ultrasonography (EUS). The patients serum IgG4 was elevated at 3.8 g/l (range 0.08-1.4 g/l). She was diagnosed with AIP type 1 and treated with prednisone (initial dose of 30 mg per day, then tapered by 5 mg/day every week). The maintenance dose of 5 mg per day was continued for 6 months. Despite clinical and radiological remission, serum levels of IgG4 remained elevated. The patient experienced disease relapse 25 months after frst attack. Moreover, new fnding of calcifcations occured in pancreas. The relapse was managed with corticosteroids and maintenance immunosupression with azathioprin was started. Literature review on risk factor of relapse, long-term immunosupressive therapy indication and optimal follow-up of AIP type 1 patients are discussed.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.